LORD, ABBETT & CO. LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$7,860,000
+53.5%
766,792
+79.9%
0.01%
-25.0%
Q1 2014$5,119,000
+17.8%
426,208
+5.6%
0.01%
+20.0%
Q3 2013$4,345,000403,4670.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Perceptive Advisors 12,528,120$38,210,0001.53%
Cormorant Asset Management, LP 850,000$2,593,0000.41%
Palo Alto Investors LP 1,656,644$5,053,0000.24%
Granahan Investment Management 1,745,604$5,324,0000.16%
Spark Investment Management LLC 318,500$980,0000.13%
Opus Point Partners Management, LLC 57,747$176,0000.10%
SHEPHERD KAPLAN KROCHUK, LLC 76,472$233,0000.06%
Joel Isaacson & Co., LLC 70,660$216,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$229,0000.05%
Cornerstone Capital, Inc. 59,200$181,0000.04%
View complete list of ACELRX PHARMACEUTICALS INC shareholders